COMMUNIQUÉS West-GlobeNewswire

Mint Ops Launches Its Fifth Division: Transition Consulting to Support Dental Clinic Owners Through Growth, Buy/Sell Decisions, and Operational Success
02/01/2026
Winnipeg, Manitoba, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Mint Ops Logo FOR IMMEDIATE RELEASE Winnipeg, MB - January 2nd, 2026 - Mint Ops, a national ecosystem of services supporting dental clinics across Canada, today [...]
Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
02/01/2026
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, [...]
Nova Leap Health Corp. Announces Promotion of Melissa Anderson to Senior Vice President, United States
02/01/2026
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Jan. 02, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Cannara atteint #1 en parts de marché au Québec en décembre 2025 et présente une mise à jour sur le lancement de ses produits de vapotage au Québec
02/01/2026
MONTRÉAL, Québec, 02 janv. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») ( TSXV : LOVE ) ( OTCQB : LOVFF ) ( FRA : 8CB0) , producteur verticalement intégré de [...]
Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch
02/01/2026
MONTREAL, Québec, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade [...]
BridgeBio to Host Achondroplasia Investor Webinar on Friday, January 9th at 8:00 am ET
02/01/2026
PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company [...]
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
02/01/2026
WESTLAKE VILLAGE, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation ( NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Jason Litten, M.D., as Chief Medical [...]
As Flu Surge Continues, Polyrizon's Nasal Spray Emerges as Potential Extra Shield Solution for Both Vaccinated and Unvaccinated
02/01/2026
Raanana, Israel, Jan. 02, 2026 (GLOBE NEWSWIRE) -- As the 2025-2026 flu season intensifies across the United States, a mutated strain of influenza A is driving most cases, sparking concerns about a potentially tough [...]
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
02/01/2026
Engagement reinforces CDT’s strategy to unlock value from its solid-form asset portfolio NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 02, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company [...]
Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel
02/01/2026
PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Mesoblast Announces Changes to Board of Directors' Leadership Roles
02/01/2026
NEW YORK, Jan. 01, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that as foreshadowed at the recent Annual [...]
Best ACV Gummies 2026 Report: True Keto Fusion Analyzed in New Year Keto-ACV Industry Analysis
01/01/2026
An Informational Buyer's Guide to Apple Cider Vinegar Gummies, BHB Ketogenic Support Ingredients, Weight Wellness Formulations, and What Label Transparency Reveals as Consumers Search "Best ACV Gummies" Entering 2026 [...]
Best CBD Gummies 2026 Consumer Report: Full Spectrum Formulations, Lab Testing Standards, and State Legal Requirements Examined in Consumer Wellness Category Analysis
01/01/2026
As January 2026 wellness searches peak, this consumer education analysis examines how informed buyers evaluate CBD gummies for sleep and stress — comparing spectrum types, verifying third-party lab testing, navigating [...]
Caring Heart Placement Announces Expanded Senior Care Advisory Initiatives in Scottsdale, Arizona
01/01/2026
SCOTTSDALE, AZ, Jan. 01, 2026 (GLOBE NEWSWIRE) -- Caring Heart Placement today announced the expansion of its senior care advisory initiatives across the greater Scottsdale and Phoenix area, introducing a more [...]
Life Line Screening (Updated): What You Need to Know?
01/01/2026
New York City,, Jan. 01, 2026 (GLOBE NEWSWIRE) -- in 2026, The greatest way to stay healthy and avoid illnesses is to notice the symptoms of the illness before it takes hold. Most deaths from unexpected heart attacks [...]
Heal N Soothe (Updated): Does It Work For Chronic Pain?
01/01/2026
New York City,, Jan. 01, 2026 (GLOBE NEWSWIRE) -- In 2026, Millions of people suffer from chronic back and joint pain and many other types of pain. But no one has found a permanent solution for these pains. One [...]
Best Keto Gummies for 2026: BHB Supplement Guide Examines What Consumers Should Know Before Buying
01/01/2026
Revra Keto BHB Gummies highlighted among ketogenic supplements as independent analysis examines full spectrum BHB formulations, exogenous ketone research, consumer evaluation criteria, and realistic expectations for [...]
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
31/12/2025
FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLA ISELIN, N.J., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the [...]
Alvotech Secures Term Loan Facility of USD 100 Million
31/12/2025
USD 100 million senior term loan facility with a 2-year maturity Strengthens liquidity to support execution across Alvotech’s R&D pipeline and global product launches through 2026 Led by GoldenTree Asset Management [...]

Pages